Oliver Kepp
Oliver Kepp
INSERM UMR1138 / Gustave Roussy Cancer Center
Verified email at gustaveroussy.fr - Homepage
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
9242*2016
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L Galluzzi, I Vitale, JM Abrams, ES Alnemri, EH Baehrecke, ...
Cell Death & Differentiation 19 (1), 107-120, 2012
24262012
Molecular mechanisms of cisplatin resistance
L Galluzzi, L Senovilla, I Vitale, J Michels, I Martins, O Kepp, M Castedo, ...
Oncogene 31 (15), 1869-1883, 2012
16272012
Immunogenic cell death in cancer therapy
G Kroemer, L Galluzzi, O Kepp, L Zitvogel
Annual review of immunology 31, 51-72, 2013
15452013
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
12802018
Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
M Michaud, I Martins, AQ Sukkurwala, S Adjemian, Y Ma, P Pellegatti, ...
Science 334 (6062), 1573-1577, 2011
9162011
Immunogenic cell death in cancer and infectious disease
L Galluzzi, A Buqué, O Kepp, L Zitvogel, G Kroemer
Nature Reviews Immunology 17 (2), 97, 2017
7892017
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, JM Bravo-San Pedro, I Vitale, SA Aaronson, JM Abrams, ...
Cell Death & Differentiation 22 (1), 58-73, 2015
7502015
Immunological effects of conventional chemotherapy and targeted anticancer agents
L Galluzzi, A Buque, O Kepp, L Zitvogel, G Kroemer
Cancer cell 28 (6), 690-714, 2015
6872015
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins, F Ghiringhelli, ...
Oncogene 29 (4), 482-491, 2010
6862010
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ...
Cell Death & Differentiation 16 (8), 1093-1107, 2009
6632009
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
T Panaretakis, O Kepp, U Brockmeier, A Tesniere, AC Bjorklund, ...
The EMBO journal 28 (5), 578-590, 2009
5742009
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301-1309, 2014
5562014
Immune parameters affecting the efficacy of chemotherapeutic regimens
L Zitvogel, O Kepp, G Kroemer
Nature reviews Clinical oncology 8 (3), 151, 2011
5532011
Type I interferons in anticancer immunity
L Zitvogel, L Galluzzi, O Kepp, MJ Smyth, G Kroemer
Nature Reviews Immunology 15 (7), 405-414, 2015
5482015
Metabolic targets for cancer therapy
L Galluzzi, O Kepp, MG Vander Heiden, G Kroemer
Nature reviews Drug discovery 12 (11), 829-846, 2013
5482013
Decoding cell death signals in liver inflammation
C Brenner, L Galluzzi, O Kepp, G Kroemer
Journal of hepatology 59 (3), 583-594, 2013
5412013
Mitochondria: master regulators of danger signalling
L Galluzzi, O Kepp, G Kroemer
Nature reviews Molecular cell biology 13 (12), 780-788, 2012
5402012
Cell death assays for drug discovery
O Kepp, L Galluzzi, M Lipinski, J Yuan, G Kroemer
Nature reviews Drug discovery 10 (3), 221-237, 2011
5332011
Decoding cell death signals in inflammation and immunity
L Zitvogel, O Kepp, G Kroemer
Cell 140 (6), 798-804, 2010
5182010
The system can't perform the operation now. Try again later.
Articles 1–20